Organigram Global

Highly Engaged Employees

Organigram Global is a prominent player in the Canadian cannabis industry, focusing on producing high-quality, indoor-grown cannabis for both medical patients and recreational consumers. Founded in 2013, the company has established a significant domestic presence and is actively pursuing international business partnerships to expand its global footprint. Organigram Global's product portfolio includes a range of legal adult-use recreational cannabis brands such as The Edison Cannabis Company, Ankr Organics, and Trailblazer, offering diverse options like flower, edibles, oils, and extracts. The company operates with an employee range of 1,000-5,000 individuals across its 5 locations, demonstrating a substantial operational scale and commitment to growth. For insights into their organizational structure and leadership, you can Meet Organigram Global's team.

The company's strategic vision extends beyond product development to encompass operational excellence and market penetration. Organigram Global has secured substantial funding, including a recent $95 million Private Equity investment from British American Tobacco, underscoring investor confidence and providing capital for further expansion and innovation. With a reported revenue of $159.3 million, Organigram Global positions itself as a significant entity within the competitive landscape. Its ticker symbol is NASDAQ: OGI. The company's focus on quality, innovation, and strategic partnerships aims to solidify its market position and drive long-term value. To delve deeper into the company's financial performance and metrics, please Explore financial highlights.

Organigram Global competes with major industry players such as Aurora Cannabis, Tilray, Canopy Growth, and Cronos Group. Its strategic focus on premium indoor cultivation and brand development differentiates it in a crowded market. TheView more...